Letermovir prophylaxis for cytomegalovirus reactivation in allogeneic hematopoietic cell transplant recipients: Single center Canadian data.
Ian PangPeggy ChenGertrude V TrinhMats RembergerIgor Novitzky-BassoArmin GerbitzDennis Dong Hwan KimRajat KumarWilson LamArjun D LawJeffrey Howard LiptonAuro ViswabandyaIvan PasicJonas MattssonFotios V MichelisPublished in: European journal of haematology (2023)
Letermovir prophylaxis started at day +21 post-alloHCT reduced CMV reactivation, with no impact on posttransplant outcomes.